Metabolic syndrome as independent risk factor among sample of Egyptian women with breast cancer

Bulletin of the National Research Centre

Table 1 MetS parameters in the two study groups

MetS parameters	Breast cancer group BC (mean ± SD)	Control group CG (mean ± SD)	Test value	P value
BMI (kg/m²)	33.84 ± 12.94	27.51 ± 7.10	−4.133•	0.000**
Waist circumference (cm)	100.30 ± 14.44	84.33 ± 13.78	−8.150•	0.000**
TG (mg/dL)	130.95 ± 58.57	119.29 ± 51.60	−1.507•	0.133
HDL cholesterol (mg/dL)	48.97 ± 12.53	41.7 ± 97.97	−4.723•	0.000**
Systolic BP (mm Hg)	132.30 ± 12.62	123.55 ± 2.59	−6.305•	0.000**
diastolic BP (mmHg)	85.82 ± 5.98	75.58 ± 3.81	−14.105•	0.000**
Fasting plasma glucose (mg/dL)	109.72 ± 51.31	78.49 ± 22.79	−5.292•	0.000**
Insulin (mIU/L)	13.6 (10 – 24.9)	6.8 (5.8—7.5)	−10.084^‡	0.000**

BMI body mass index, TG triglyceride, HDL high-density lipoprotein, BP blood pressure
P value > 0.05: non-significant; P value < 0.05: Significant (*); and P value < 0.01: highly significant (**)
•Independent t test
^‡Mann–Whitney test
≠ All data were presented as mean ± SD except insulin level presented as median (IQR) due to nonparametric distribution